Tyng-Yuang Jang

45PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Oct 08, 2026
The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE-B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B.

|Aug 04, 2026
Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.

|Apr 23, 2026
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

|Dec 26, 2025
Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication.

Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh

|Nov 22, 2025
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD.

Ya-Chin Huang, Chih-Wen Wang, Jiun-Chi Huang

|Jul 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis B.

Tyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang

Pageof 8

Frequent Collaborators

29 joint publications

Chung-Feng Huang

27 joint publications

Ming-Lung Yu

25 joint publications

Ming-Lun Yeh

15 joint publications

Po-Yau Hsu